125 results
Page 4 of 7
8-K
EX-99.1
leimf4o pf50
19 Jun 19
Departure of Directors or Certain Officers
5:17pm
D
srn8pl6f7galm7888k
6 Jun 19
$10.13M in options / securities to be acquired, 7 investors
12:00am
8-K
EX-99.1
gah0a1g xk
8 May 19
Biocept Reports First Quarter 2019 Financial Results
4:33pm
D
2gykthd 27ya4cv52
29 Mar 19
$7.44M in options / securities to be acquired, 7 investors
4:06pm
8-K
EX-99.1
mxnu1vuf2u
29 Mar 19
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results
12:00am
8-K
EX-10.1
hv5k1lp6e0p3fqz78ak
18 Mar 19
Biocept Announces Pricing of $8.2 Million Registered Direct Offering
12:00am
8-K
EX-10.2
nuyew4
18 Mar 19
Biocept Announces Pricing of $8.2 Million Registered Direct Offering
12:00am
424B4
dhglgz56gp4tozy8jiva
11 Feb 19
Prospectus supplement with pricing info
12:00am
8-K
EX-10.1
4z9rn
18 Jan 19
Biocept Announces Pricing of $2.2 Million Registered Direct Offering
4:51pm
8-K
EX-10.2
4ge1b9
18 Jan 19
Biocept Announces Pricing of $2.2 Million Registered Direct Offering
4:51pm
8-K
EX-99.1
c5ku dlein
13 Nov 18
Biocept Reports Third Quarter 2018 Financial Results
4:14pm
S-8
EX-99.1
7gcptpi
19 Oct 18
Registration of securities for employees
4:34pm
D
njuasz2
3 Oct 18
$2.41M in options / securities to be acquired, 4 investors
4:10pm
8-K
EX-10.2
wsks7s5
21 Sep 18
Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market
9:57pm